Wednesday, July 8, 2026

biotech · Hypertension · Essential Hypertension · QNTM

Quantum Pharmaceuticals

Quantum Pharmaceuticals is a biotech organization headquartered in Moscow, CA. It trades on NYSE under ticker QNTM. Primary therapeutic focus areas include Hypertension, Essential Hypertension, Breast Cancer, Metastatic

volkova 6A-1206, Moscow, 141700, RU, CA HQ
2004 Founded
29 Employees
Public company Type
QNTM · NYSE Ticker
Company details
Status
Public
HQ
volkova 6A-1206, Moscow, 141700, RU, CA
Founded
2004
Employees
29
Programs
18
Drugs
17
Patents
36
Clinical program

QGC001

Phase 2 · small molecule · Essential Hypertension

QGC001 for Essential Hypertension is a Phase 2 program (small_molecule) at Quantum Biopharma with 1 ClinicalTrials.gov record(s).

← All Quantum Biopharma projects Phase 2 small molecule completed

Internal code QGC001/2QG1

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Quantum Biopharma
Phase
Phase 2
Modality
small_molecule
Indication
Essential Hypertension
Status
completed
Trials
1

Clinical trials